Pharmaceutical - Nephrology and Hepatology

Filter

Current filters:

Nephrology and Hepatology

Popular Filters

1 to 25 of 99 results

Novo Nordisk's Victoza granted label extension in the UK

Novo Nordisk's Victoza granted label extension in the UK

20-01-2015

A license extension has been granted in the UK for Victoza (liraglutide) from Danish insulin giant Novo…

Nephrology and HepatologyNovo NordiskPharmaceuticalRegulationUKVictoza

Regado and Tobira to merge to create leading NASH company

Regado and Tobira to merge to create leading NASH company

14-01-2015

The USA’s Regado Biosciences and privately-held Tobira Therapeutics have entered into a definitive…

Mergers & AcquisitionsNephrology and HepatologyPharmaceuticalRegadoTobira TherapeuticsUSA

Debiopharm regains rights to alisporivir in hepatitis C from Novartis

Debiopharm regains rights to alisporivir in hepatitis C from Novartis

13-01-2015

Switzerland-based biopharma company Debiopharm has updated its arrangement with Novartis to regain full…

alisporivirDebiopharmLicensingNephrology and HepatologyNovartisPharmaceuticalResearch

CVS to cover Gilead’s hepatitis C drugs Harvoni and Sovaldi exclusively

CVS to cover Gilead’s hepatitis C drugs Harvoni and Sovaldi exclusively

06-01-2015

US pharmacy benefits manager CVS Health has entered into a deal with US biotech major Gilead Sciences…

GileadHarvoniNephrology and HepatologyPharmaceuticalPricingSovaldiUSA

Takeda ends partnership with AMAG Pharma on Rienso/Feraheme

Takeda ends partnership with AMAG Pharma on Rienso/Feraheme

30-12-2014

Japan’s largest drugmaker Takeda Pharmaceutical has entered into an agreement with US drugmaker AMAG…

AMAG PharmaceuticalsCanadaEuropeFerahemeHematologyLicensingNephrology and HepatologyPharmaceuticalRiensoTakeda Pharmaceutical

Achillion shares jump on positive interim results from ACH-3102 and ACH-322 for hepatitis C

Achillion shares jump on positive interim results from ACH-3102 and ACH-322 for hepatitis C

23-12-2014

US pharma company Achillion Pharmaceuticals saw its shares jump as much as 60% on the announcement of…

ACH-3102ACH-3422Achillion PharmaceuticalsNephrology and HepatologyPharmaceuticalResearchUSA

Sanofi accused of $34 million kickbacks by former paralegal employee

Sanofi accused of $34 million kickbacks by former paralegal employee

05-12-2014

Allegations have been made that French drug major Sanofi and members of its executive took part in a…

FranceLantusLegalNephrology and HepatologyPharmaceuticalSanofi

France negotiates lowest price in Europe for Gilead’s Sovaldi

France negotiates lowest price in Europe for Gilead’s Sovaldi

21-11-2014

The discount negotiated by the French government on hepatitis C drug Sovaldi (sofosbuvir), produced by…

FranceGilead SciencesNephrology and HepatologyPharmaceuticalPoliticsPricingRegulationSovaldi

Kissei files for Japanese approval of PA21 for hyperphosphatemia

21-11-2014

Japanese mid-sized drugmaker Kissei Pharmaceutical says that a new drug application for PA21 (development…

FreseniusJapanKissei PharmaceuticalNephrology and HepatologyPA21PharmaceuticalRegulationVelphoroVifor Pharma

Takeda joins forces with GE Healthcare on liver disease research

Takeda joins forces with GE Healthcare on liver disease research

13-11-2014

Japan’s largest drugmaker Takeda Pharmaceutical has entered into an alliance agreement with UK-based…

GE HealthcareJapanNephrology and HepatologyPharmaceuticalResearchTakeda Pharmaceutical

Merck's Phase II trial of grazoprevir/elbasvir in hepatitis C genotype 1 positive

Merck's Phase II trial of grazoprevir/elbasvir in hepatitis C genotype 1 positive

12-11-2014

Pharma giant Merck & Co has presented results from its Phase II trial of grazoprevir/elbasvir, with or…

grazoprevir/elbasvirMerck & CoNephrology and HepatologyPharmaceuticalResearchUSA

Two Bristol-Myers Squibb drugs approved by Scottish Medicines Consortium

Two Bristol-Myers Squibb drugs approved by Scottish Medicines Consortium

10-11-2014

The Scottish Medicines Consortium has approved two new treatments today, one for skin cancer and one…

Bristol-Myers SquibbDaklinzaNephrology and HepatologyOncologyPharmaceuticalRegulationUKYervoy

Islet Sciences announces merger with Brighthaven Ventures

Islet Sciences announces merger with Brighthaven Ventures

01-10-2014

Metabolic biopharma specialist Islet Sciences has announced a merger with Brighthaven Ventures, a privately-held…

Islet SciencesMergers & AcquisitionsNephrology and HepatologyPharmaceuticalremogliflozinUSA

Achillion a good candidate for collaboration or takeover based on hepatitis C candidate, says Edison

Achillion a good candidate for collaboration or takeover based on hepatitis C candidate, says Edison

29-09-2014

Achillion Pharmaceuticals is in a prime position to develop its own all-oral hepatitis C treatment as…

Achillion PharmaceuticalsFinancialMarkets & MarketingNephrology and HepatologyPharmaceuticalUSA

OPKO's second Rayaldee Ph III trial meets primary endpoints

OPKO's second Rayaldee Ph III trial meets primary endpoints

24-09-2014

US drugmaker OPKO Health has released successful top-line results from the second and final pivotal Phase…

Nephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeResearchUSA

Keryx' shares fall as FDA approves kidney drug, but with warnings

Keryx' shares fall as FDA approves kidney drug, but with warnings

07-09-2014

US drugmaker Keryx Biopharmaceuticals has received approval from the US Food and Drug Administration…

ferric citrateKeryx BiopharmaceuticalsNephrology and HepatologyPharmaceuticalRegulationRenvelaSanofiUSAZerenex

Bristol-Myers Squibb launches Daklinza in the UK for chronic hepatitis C

Bristol-Myers Squibb launches Daklinza in the UK for chronic hepatitis C

03-09-2014

US drug major Bristol-Myers Squibb has launched Daklinza (daclastavir) in the UK for chronic hepatitis…

AntiviralsBristol-Myers SquibbDaklinzaHepatitis CNephrology and HepatologyPharmaceuticalRegulationUK

AstraZeneca and Mitsubishi Tanabe Pharma to collaborate on diabetic nephropathy

AstraZeneca and Mitsubishi Tanabe Pharma to collaborate on diabetic nephropathy

20-08-2014

Anglo-Swedish drug major AstraZeneca has entered into a three-year research collaboration on diabetic…

AstraZenecaChronic kidney diseaseDiabetesJapanKidney diseasesMitsubishi TanabeNephrology and HepatologyPharmaceuticalResearchSweden

Intercept shares rocket on positive liver drug results

Intercept shares rocket on positive liver drug results

12-08-2014

Shares of US drug developer Intercept Pharmaceuticals leapt 53% to $358.07 in after-hours trading on…

Intercept PharmaceuticalsLiver diseaseNephrology and Hepatologyobeticholic acidPharmaceuticalResearchUSA

OPKO’s Rayaldee Ph III trial meets primary endpoints in SHPT

12-08-2014

US drugmaker OPKO Health has released positive top-line results from the first pivotal Phase III trial…

Endocrine systemJoel MelnickNephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeResearchUSAVitamin D

NICE issues new quality standard to prevent hepatitis B transmission

NICE issues new quality standard to prevent hepatitis B transmission

28-07-2014

On World Hepatitis Day today, the UK’s clinical standards body, the National Institute for Health and…

BaracludeBristol-Myers SquibbGilead SciencesHealthHepatitis BHepatologyMedicineNephrology and HepatologyPharmaceuticalPurinesRegulationUKViread

1 to 25 of 99 results

Back to top